Bilaketaren emaitzak - Ronit Simantov

Findu emaitzak
  1. 1
    Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1

    Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1 nork Ronit Simantov, Maria Febbraio, René Crombie, Adam S. Asch, Ralph L. Nachman, Roy L. Silverstein

    Argitaratua 2001
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database

    Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database nork André P. Fay, Rana R. McKay, Xun Lin, Ronit Simantov, Toni K. Choueiri

    Argitaratua 2018
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II

    High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II nork Keying Ma, Ronit Simantov, Jing-Chuan Zhang, Roy L. Silverstein, Katherine A. Hajjar, Keith R. McCrae

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients with Renal Cell Carcinoma

    Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients with Renal Cell Carcinoma nork Rana R. McKay, Xun Lin, Julia Jane Perkins, Daniel Y.C. Heng, Ronit Simantov, Toni K. Choueiri

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

    Activation of cultured vascular endothelial cells by antiphospholipid antibodies. nork Ronit Simantov, J M LaSala, S K Lo, A E Gharavi, Lisa R. Sammaritano, Jane E. Salmon, Roy L. Silverstein

    Argitaratua 1995
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Depth of Remission is a Prognostic Factor for Survival in Patients with Metastatic Renal Cell Carcinoma

    Depth of Remission is a Prognostic Factor for Survival in Patients with Metastatic Renal Cell Carcinoma nork Viktor Grünwald, Rana R. McKay, Katherine M. Krajewski, D. Kalanovic, Xun Lin, Julia Jane Perkins, Ronit Simantov, Toni K. Choueiri

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo

    Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo nork Ling Qi, Andrew T. Jacovina, Arunkumar B. Deora, Maria Febbraio, Ronit Simantov, Roy L. Silverstein, Barbara Hempstead, Willie Mark, Katherine A. Hajjar

    Argitaratua 2004
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma

    Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma nork Rana R. McKay, Gustavo E. Rodriguez, Xun Lin, Marina D. Kaymakcalan, Ole‐Petter R. Hamnvik, Venkata Sabbisetti, Rupal S. Bhatt, Ronit Simantov, Toni K. Choueiri

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice

    Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice nork Hayes M. Dansky, Sherri A. Charlton, John L. Sikes, Simon Heath, Ronit Simantov, Lawrence F. Levin, Pei Shu, Karen J. Moore, Jan L. Breslow, Jonathan D. Smith

    Argitaratua 1999
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors

    A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors nork Igor Puzanov, Colin R. Lindsay, Laura W. Goff, Jeff Sosman, Jill Gilbert, Jordan Berlin, Srinivasu Poondru, Ronit Simantov, Rich Gedrich, Andrew Stephens, Emily Chan, T.R. Jeffry Evans

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer

    Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer nork Alex A. Adjei, Julian R. Molina, Sumithra J. Mandrekar, Randolph S. Marks, Joel R. Reid, Gary A. Croghan, Lorelei J. Hanson, James R. Jett, Chenghua Xia, Chetan Lathia, Ronit Simantov

    Argitaratua 2007
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer

    Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer nork April A. N. Rose, Andrée‐Anne Grosset, Zhifeng Dong, Caterina Russo, Patricia MacDonald, Nicholas Bertos, Yves St‐Pierre, Ronit Simantov, Michael Hallett, Morag Park, Louis Gaboury, Peter M. Siegel

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors

    Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors nork Robin L. Jones, Edward S. Kim, Pilar Nava-Parada, Salma Alam, Faye M. Johnson, Andrew Stephens, Ronit Simantov, Srinivasu Poondru, Rich Gedrich, Scott M. Lippman, Stan B. Kaye, Craig P. Carden

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus

    Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus nork Mary J. Roman, Beth‐Ann Shanker, Adrienne Davis, Michael D. Lockshin, Lisa R. Sammaritano, Ronit Simantov, Mary K. Crow, Joseph E. Schwartz, Stephen A. Paget, Richard B. Devereux, Jane E. Salmon

    Argitaratua 2003
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Statins and survival outcomes in patients with metastatic renal cell carcinoma

    Statins and survival outcomes in patients with metastatic renal cell carcinoma nork Rana R. McKay, Xun Lin, Laurence Albigès, André P. Fay, Marina D. Kaymakcalan, Suzanne S Mickey, P. Peter Ghoroghchian, Rupal S. Bhatt, Samuel Kaffenberger, Ronit Simantov, Toni K. Choueiri, Daniel Yick Chin Heng

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma nork Patrick A. Ott, Omid Hamid, Anna C. Pavlick, Harriet M. Kluger, Kevin B. Kim, Peter D. Boasberg, Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, Thomas A. Davis, Mario Sznol, Patrick Hwu

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer

    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer nork Johanna C. Bendell, Mansoor N. Saleh, April A. N. Rose, Peter M. Siegel, Lowell L. Hart, Surendra Sirpal, Suzanne F. Jones, Jennifer Green, Elizabeth Crowley, Ronit Simantov, Tibor Keler, Thomas A. Davis, Linda T. Vahdat

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis nork Tim Eisen, T. Ahmad, Keith T. Flaherty, Martin Gore, Stan B. Kaye, Richard Marais, I. Gibbens, Samuel Hackett, Maggie James, Lynn M. Schuchter, Katherine L. Nathanson, Chenjing Xia, Ronit Simantov, Brian Schwartz, Melanie Poulin-Costello, Peter J. O’Dwyer, Mark J. Ratain

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma

    Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma nork Aly‐Khan A. Lalani, Wanling Xie, David A. Braun, Marina D. Kaymakcalan, Dominick Bossé, John A. Steinharter, Dylan J. Martini, Ronit Simantov, Xun Lin, Xiao X. Wei, Bradley A. McGregor, Rana R. McKay, Lauren C. Harshman, Toni K. Choueiri

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

    Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma nork Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, M. Siebels, Sylvie Négrier, Christine Chevreau, E Solska, Apurva A. Desai, Frédéric Rolland, Tomasz Demkow, Thomas E. Hutson, Martin Gore, Sara M. Freeman, Brian Schwartz, Minghua Shan, Ronit Simantov, Ronald M. Bukowski

    Argitaratua 2007
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: